Association of glycated hemoglobin A(1c) levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium

BACKGROUND: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobin A(1c) (HbA(1c)) is used to monitor the quality of diabetes treatment. Its strength of association with cardiovascular outcomes in the general population remains uncertain. This study aims to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinning, Christoph, Makarova, Nataliya, Völzke, Henry, Schnabel, Renate B., Ojeda, Francisco, Dörr, Marcus, Felix, Stephan B., Koenig, Wolfgang, Peters, Annette, Rathmann, Wolfgang, Schöttker, Ben, Brenner, Hermann, Veronesi, Giovanni, Cesana, Giancarlo, Brambilla, Paolo, Palosaari, Tarja, Kuulasmaa, Kari, Njølstad, Inger, Mathiesen, Ellisiv Bøgeberg, Wilsgaard, Tom, Blankenberg, Stefan, Söderberg, Stefan, Ferrario, Marco M., Thorand, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594211/
https://www.ncbi.nlm.nih.gov/pubmed/34781939
http://dx.doi.org/10.1186/s12933-021-01413-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594211/
https://www.ncbi.nlm.nih.gov/pubmed/34781939
http://dx.doi.org/10.1186/s12933-021-01413-4

Ejemplares similares